Seizure: European Journal of Epilepsy
Volume 17, Issue 6 , Pages 531-534 , September 2008

Lamotrigine and catamenial epilepsy

Received 25 November 2006 ,Revised 1 October 2007 ,Accepted 29 February 2008.

References 

  1. Duncan S, Read CL, Brodie M. How common is catamenial epilepsy. Epilepsia. 1993;34:827–831
  2. Herzog AG, Klein P, Ransil BY. Three patterns of catamenial epilepsy. Epilepsia. 1997;38:1082–1088
  3. Morrell MJ, Handy SF, Seale CG, Springer EA. Self reported reproductive history in women with epilepsy: puberty onset and effects of menarche and menstrual cycle on seizures. Neurology. 1998;50:448;[Abstract]
  4. Herzog AG, Frye CA. Seizure exacerbation associated with inhibition of progesterone metabolism. Ann Neurol. 2003;53:390–391
  5. Lonsdale O, Burnham WM. The anticonvulsant effects of progesterone and 5α dihydroprogesterone on amydala-kindled seizures in rats. Epilepsia. 2003;44:1494–1499
  6. Lundberg PO. Catamenial epilepsy: a review. Cephalgia. 1997;17(Suppl. 20):S42–S45
  7. Lim LL, Foldvary N, Mascha E, Lee J. Acetazolamide in women with catamenial epilepsy. Epilepsia. 2001;42:746–749
  8. Krishnamurthy B, Schomer DL. Weekly fluctuation and adjustment of antiepileptic drugs to treat catamenial seizures. Epilepsia. 1998;39(Suppl. 6):179;[abstract]
  9. Ramaratham S. Successful treatment of a patient with refractory catamenial epilepsy with lamotrigine SYCP. Epilepsy. 2003;10:18–20
  10. Herzog AG. Progesterone therapy in women with epilepsy: a three year follow-up. Neurology. 1999;52(9):1917–1918
  11. Morrell MY. Epilepsy in women: the science of why it is special. Neurology. 1999;53(Suppl. 1):S42–S48
  12. Reddy DS, Castaneda DC, O’Malley BW, Rogawski MA. Anticonvulsant activity of progesterone and neurosteroid in progesterone receptor knockout mice. J Pharmacol Exp Ther. 2004;310:230–239

PII: S1059-1311(08)00051-4

doi: 10.1016/j.seizure.2008.02.001

Seizure: European Journal of Epilepsy
Volume 17, Issue 6 , Pages 531-534 , September 2008

Article Tools